World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
54
Citations
12966
World Ranking
15482
National Ranking
6460

Li Shen publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Li Shen sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 445 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Li Shen D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Li Shen sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 54 D-Index — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Li Shen is affiliated with the Icahn School of Medicine at Mount Sinai in the United States and specializes in fields spanning Medicine and Biochemistry, Genetics and Molecular Biology. Their research output includes 142 publications in medicine and 134 in biochemistry and related molecular biology disciplines, with deep involvement in molecular biology, oncology, cancer research, immunology, and pulmonary and respiratory medicine.

The scientist's work addresses several main topics, such as lung cancer research studies, microtubule and mitosis dynamics, RNA modifications and cancer, antimicrobial resistance in Staphylococcus, bacterial biofilms and quorum sensing, cancer-related molecular pathways, and microRNA in disease regulation.

They have frequently published in several scientific venues, with the highest number of publications appearing in Cancer Research, followed by Clinical Cancer Research, bioRxiv, Microbiology Spectrum, and Frontiers in Immunology.

Li Shen has collaborated extensively, with frequent coauthors including Jing Wang, Faye M. Johnson, Lauren A. Byers, John V. Heymach, and Carl M. Gay. These collaborations highlight a network of researchers working together in related biomedical and cancer research fields.

Selected recent publications by Li Shen include:

  • "Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial," 2021, The Lancet Neurology
  • "A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components," 2020, Science Translational Medicine
  • "IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC," 2023, Clinical Cancer Research
  • "Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial," 2022, The Lancet Neurology
  • "CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance," 2023, Cancer Cell

Best Publications

  • An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

    Lauren Averett Byers;Lixia Diao;Jing Wang;Pierre Saintigny

  • Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites.

    S. Colella;L. Shen;Keith A Baggerly;J. P.J. Issa

  • Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

    Lauren Averett Byers;Jing Wang;Monique B. Nilsson;Junya Fujimoto

  • Entinostat neutralizes myeloid derived suppressor cells and enhances the antitumor effect of PD-1 inhibition in murine models of lung and renal cell carcinoma

    Ashley Orillion;Ashley Orillion;Ayumi Hashimoto;Nur P Damayanti;Li Shen

  • Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers

    Ana M. Aparicio;Li Shen;Elsa M Li Ning Tapia;Jing-Fang Lu

  • Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas

    Tiffany A Doucette;Ganesh Rao;Arvind Rao;Li Shen

  • Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models

    Li Shen;Michael Ciesielski;Swathi Ramakrishnan;Kiersten M. Miles

  • Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study

    Hans J. Hammers;Henk M. Verheul;Henk M. Verheul;Brenda Salumbides;Rajni Sharma

  • miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer

    J Gao;N Li;Y Dong;S Li

  • A promising biodegradable magnesium alloy suitable for clinical vascular stent application

    Lin Mao;Li Shen;Jiahui Chen;Xiaobo Zhang

  • The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

    Vassiliki Papadimitrakopoulou;J. Jack Lee;Ignacio I. Wistuba;Anne S. Tsao

  • Mesenchymal Stem Cells Regulate Blood-Brain Barrier Integrity Through TIMP3 Release After Traumatic Brain Injury

    Tyler Menge;Yuhai Zhao;Jing Zhao;Kathryn Wataha

  • Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates.

    Vida Chitsazzadeh;Cristian Coarfa;Jennifer A. Drummond;Tri Nguyen

  • Synthetic ePTFE grafts coated with an anti-CD133 antibody-functionalized heparin/collagen multilayer with rapid in vivo endothelialization properties.

    Shuyang Lu;Peng Zhang;Xiaoning Sun;Feirong Gong

  • YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage

    Eric Stefano Ciamporcero;Eric Stefano Ciamporcero;H Shen;S Ramakrishnan;S Yu Ku

  • Enhanced Bioactivity of Mg–Nd–Zn–Zr Alloy Achieved with Nanoscale MgF2 Surface for Vascular Stent Application

    Lin Mao;Li Shen;Jiahui Chen;Yu Wu;Yu Wu

  • A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components

    Monique B. Nilsson;Huiying Sun;Jacqulyne Robichaux;Matthias Pfeifer

  • Rapid optimization of drug combinations for the optimal angiostatic treatment of cancer

    Andrea Weiss;Andrea Weiss;Xianting Ding;Judy R. van Beijnum;Ieong Wong

  • Integrative Analysis Identifies a Novel AXL-PI3 Kinase-PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer.

    Heath Skinner;Uma Giri;Liang P. Yang;Manish Kumar

  • Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

    G.D. Demetri;C.R. Antonescu;B. Bjerkehagen;J.V.M.G. Bovée

Frequent Co-Authors

Eric J. Nestler
Eric J. Nestler Icahn School of Medicine at Mount Sinai
Rachael L. Neve
Rachael L. Neve Harvard University
Jian Feng
Jian Feng University at Buffalo, State University of New York
Yi Zhang
Yi Zhang Harvard University
Heng-Yu Fan
Heng-Yu Fan Zhejiang University
Gustavo Turecki
Gustavo Turecki Douglas Mental Health University Institute
Rosemary C. Bagot
Rosemary C. Bagot McGill University
Bin Zhang
Bin Zhang Icahn School of Medicine at Mount Sinai
Xin-Hua Feng
Xin-Hua Feng Zhejiang University
Ja Wook Koo
Ja Wook Koo Korea Brain Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Graduates in Biology and Biochemistry often branch into allied health fields, where online degrees are increasingly popular. One in-demand pathway is Health Information Management (HIM), prized for its blend of technology and healthcare. Many students seek the most affordable online health information management degree programs to launch their careers in this expanding field.

Medical coding is another top option, offering strong job growth and good earning potential. To learn more about medical coding jobs salary and entry pathways, explore online coursework and short-term certifications available nationwide.

Choosing between credentials such as a certified professional coder (CPC) or a certified coding specialist (CCS) is an important decision, as each offers different advantages, costs, and salary prospects.

Is medical coding a good job for science graduates? Consider your personality, work environment preferences, and salary goals. For an honest look at this career, read about the is medical coding a good job question before making your choice.

Best Scientists Citing Li Shen

Trending Scientists

Recently Published Articles